Cryogenic Solutions Inc. (CYGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nancy McKinney who wrote (794)	7/19/1998 11:35:00 AM
From: Janice Shell	Read Replies (1) of 4028

...solid research into the foundations of anti-ageing IS a breakthrough. 1. What proof do you have that CYGS's research is "solid"? 2. My understanding in any case is that the technology that CYGS hopes to sell wasn't developed by them: In April 1997, CSI licensed technology and began perfecting the patent for their TeloVector(TM) designed to synthesize sequence specific single strands of DNA (ssDNA) in cells (in vivo) to repair telomere ends shortened during cell division (mitosis). biz.yahoo.com and This in vivo expression of single-stranded DNA (ssDNA) that is complementary to an RNA template encoded in a vector was accomplished under a sponsored research agreement by CSI... CSI holds the patent rights of this and related technology developed under the sponsored research agreement. although the press release in question bears the title: CSI Researchers Express ssDNA in Vivo. biz.yahoo.com 3. This kind of research is currently being engaged in by dozens of biotech firms.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next